4//SEC Filing
ZS Pharma, Inc. 4
Accession 0000899243-15-010249
CIK 0001459266operating
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 8:26 PM ET
Size
11.1 KB
Accession
0000899243-15-010249
Insider Transaction Report
Form 4
ZS Pharma, Inc.ZSPH
Devon Park Associates, L.P.
10% Owner
Transactions
- Disposition from Tender
Common Stock
2015-12-17$90.00/sh−2,576,724$231,905,160→ 0 total - Disposition from Tender
Common Stock
2015-12-17$90.00/sh−9,748$877,320→ 0 total(indirect: See Footnote)
DEVON PARK BIOVENTURES LP
10% Owner
Transactions
- Disposition from Tender
Common Stock
2015-12-17$90.00/sh−9,748$877,320→ 0 total(indirect: See Footnote) - Disposition from Tender
Common Stock
2015-12-17$90.00/sh−2,576,724$231,905,160→ 0 total
Devon Park Associates, LLC
10% Owner
Transactions
- Disposition from Tender
Common Stock
2015-12-17$90.00/sh−9,748$877,320→ 0 total(indirect: See Footnote) - Disposition from Tender
Common Stock
2015-12-17$90.00/sh−2,576,724$231,905,160→ 0 total
Footnotes (2)
- [F1]Devon Park Associates, L.P. is the holder of record of 9,748 shares of common stock of the Issuer ("Common Stock"). Devon Park Associates, LLC is the general partner of Devon Park Associates, L.P., which is the general partner of Devon Park Bioventures, L.P. Messrs. Marc Ostro, Christopher Moller and Devang Kantesaria are the founding members and managing directors of Devon Park Associates, LLC. Each such founding member (the "Founding Member") may be deemed to have shared voting and investment power over the shares beneficially owned by Devon Park Associates, L.P. and Devon Park Associates, LLC as described above. Each Founding Member disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Founding Members are the beneficial owners of such securities for Section 16 or any other purpose.
- [F2]Devon Park Bioventures, L.P. is the holder of record of 2,576,724 shares of Common Stock. Devon Park Associates, LLC is the general partner of Devon Park Associates, L.P., which is the general partner of Devon Park Bioventures, L.P. The Founding Members are the managing directors of Devon Park Associates, LLC and each such Founding Member may be deemed to have shared voting and investment power over the shares beneficially owned by the funds as described above. Each Founding Member disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the Founding Members are the beneficial owners of such securities for Section 16 or any other purpose.
Documents
Issuer
ZS Pharma, Inc.
CIK 0001459266
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001459266
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 8:26 PM ET
- Size
- 11.1 KB